SIGNIFOR

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug SIGNIFOR contains one active pharmaceutical ingredient (API):

1	Pasireotide UNII 98H1T17066 - PASIREOTIDE
	Pasireotide is a novel cyclohexapeptide, injectable somatostatin analogue. Pasireotide exerts its pharmacological activity via binding to somatostatin receptors. Somatostatin receptors are expressed in many tissues, especially in neuroendocrine tumours in which hormones are excessively secreted, including ACTH in Cushing’s disease.
	Read more about Pasireotide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SIGNIFOR Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)
SIGNIFOR Powder and solvent for suspension for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01CB05	Pasireotide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576921020000617, 576921020000717, 576921020000817
CA	Health Products and Food Branch	02413299, 02413302, 02413310
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	H5300513, H6070713, H6080713
EE	Ravimiamet	1580655, 1580666, 1580677, 1580688, 1580699, 1580701, 1580712, 1580723, 1580734, 1580745, 1580756, 1580767, 1713800, 1713811, 1713822, 1713833, 1713844, 1753208, 1753219
ES	Centro de información online de medicamentos de la AEMPS	112753013, 112753014, 112753016
FI	Lääkealan turvallisuus- ja kehittämiskeskus	382849, 466629, 483533, 493675
FR	Base de données publique des médicaments	60368028, 64400612, 64714278, 66311151, 67724733, 68045233, 68990053, 69935063
GB	Medicines & Healthcare Products Regulatory Agency	212072, 212075, 212078, 298974, 298983, 298994, 356059, 356062
HK	Department of Health Drug Office	62456, 62457, 62458
IL	מִשְׂרַד הַבְּרִיאוּת	7121, 7122
IT	Agenzia del Farmaco	042032019, 042032021, 042032033, 042032045, 042032058, 042032060, 042032072, 042032084, 042032096, 042032108, 042032110, 042032122, 042032134, 042032146, 042032159, 042032161, 042032173, 042032185, 042032197
LT	Valstybinė vaistų kontrolės tarnyba	1066383, 1066384, 1066385, 1066386, 1066387, 1066388, 1066389, 1066390, 1066391, 1066392, 1066393, 1066394, 1076182, 1076183, 1076184, 1076186, 1076187, 1084006, 1084007
NL	Z-Index G-Standaard, PRK	103519, 103527, 126047, 126055, 126063
NZ	Medicines and Medical Devices Safety Authority	17224, 17225, 17226
PL	Rejestru Produktów Leczniczych	100274591, 100274600, 100274616, 100331283, 100331290, 100331308, 100394272, 100394295
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66950001, W66951001, W66951002, W66952001, W66952002, W66953001, W66954001, W67087001, W67087002, W67087003, W67087004, W67088001, W67088002, W67088003, W67088004, W67090001, W67090002, W67090003, W67090004
SG	Health Sciences Authority	14457P, 14458P, 14459P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699960580138, 8699960580145, 8699960580152, 8699960580169, 8699960580176, 8699960580183, 8699960580190, 8699960580206, 8699960580213, 8699960580220, 8699960580237, 8699960580244
US	FDA, National Drug Code	0078-0633, 0078-0634, 0078-0635, 55292-131, 55292-132, 55292-133